Stockreport

Vistagen Therapeutics: Initial Analysis Of Fasedienol Points To Bullish [Seeking Alpha]

VistaGen Therapeutics, Inc.  (VTGN) 
Last vistagen therapeutics, inc. earnings: 2/13 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vistagen.com
PDF The company's pipeline includes candidates for social anxiety disorder, major depressive disorder, vasomotor symptoms, and more. Vistagen's financial position is stro [Read more]